Wellchem

Medications

Erlotirel Film-Coated Tablets

ErlotiRel (Erlotinib) Film-coated Tablet (100mg or 150mg) is an antineoplastic agent, specifically functioning as an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI). It inhibits the intracellular phosphorylation of HER1/EGFR receptor, resulting in cell stasis and/or death. It is administered orally.

Approved Indications:

  • First-line treatment of patients with locally advanced or metastatic non-small cell lung cancer with EGFR activating mutations.
  • Switch maintenance treatment in patients with locally advanced or metastatic NSCLC with EGFR activating mutations and stable disease after first-line chemotherapy.
  • Treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of at least one prior chemotherapy regimen.
  • In combination with gemcitabine, for the first-line treatment of patients with locally advanced, unresectable or metastatic pancreatic cancer.

Related Products